2nd Quarter - Report
SQUIRE PATTON BOGGS for RANBAXY INC.
Firm
Client
Income
$160,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
P.L. 111-148, Patient Protection and Affordable Care; P.L. 111-152, Health Care and Education Reconciliation; H.R. 3200, America's Affordable Health Choices; S. 1796, America's Healthy Futures;
Foreign entity interest: Ranbaxy Labs Limited; interests are same as registrant.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JOHN JONAS | — |
| ERIC RASMUSSEN | SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000 |
| MATTHEW TODD TUTEN | RepMichaelBilirakis91-92;93-95;98-01 |
| ANURAG VARMA | — |
Pharmacy PHA
S. 369, Preserve Access to Affordable Generics; H.R. 759, FDA Globalization
Foreign entity interest: Ranbaxy Labs Limited - Interests are same as Registrant;
| Lobbyist | Covered position, as disclosed |
|---|---|
| ERIC RASMUSSEN | SenCrapoLA04-07andDepPresSec03-02LegIntenHatch2000 |
| MATTHEW TODD TUTEN | RepMichaelBilirakis91-92;93-95;98-01 |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.